Last reviewed: July 3, 2026
Last updated: July 3, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide, the active ingredient in prescription weight loss therapy, works through a structured weekly injection pattern designed to help your body adjust gradually to the medication. Most patients begin with a low starting dose and increase incrementally over 16–20 weeks, a process called titration. PlexusDx provides compounded semaglutide injections from licensed 503A pharmacies, allowing you to follow a personalized dosing timeline without the barriers of insurance approval.
Weekly Injection Protocol for Semaglutide Treatment
Semaglutide is designed as a once-weekly subcutaneous injection, meaning you give yourself one shot beneath the skin every seven days on the same day each week. This consistent schedule allows your body to maintain steady medication levels in your bloodstream, which is essential for appetite regulation and metabolic benefits. Many patients choose Monday, Wednesday, or Friday as their injection day to create a routine they can remember easily.
The standard titration schedule starts at a 0.25 mg dose in week one and increases by 0.25 mg increments every four weeks until reaching a therapeutic dose, typically between 1.0 mg and 2.4 mg weekly. This gradual escalation approach reduces gastrointestinal side effects such as nausea and helps your system adapt to the medication's effects on blood sugar and appetite control. Clinical trials show that slower titration improves tolerability and treatment adherence compared to rapid dose increases.
Understanding Dose Titration Schedules and Timeline
Your semaglutide titration journey typically spans four to five months before reaching a stable maintenance dose that works best for your weight loss and metabolic goals. During this period, your healthcare provider monitors your response to each dose level and adjusts your injection schedule only as needed based on your individual tolerance and results. PlexusDx partners with clinical providers who create customized titration plans tailored to your health history and baseline metabolic markers.
Some patients reach their target dose in 16 weeks, while others benefit from a gentler escalation over 20 weeks or longer, especially if they experience GI sensitivity or have existing digestive conditions. Skipping weeks or pausing at a current dose level is also an option if you need additional time for your body to adjust before moving to the next increment. Your PlexusDx provider works with you to find the pace that balances efficacy with comfort and safety.
Maintaining Consistency: Weekly Injection Best Practices
Consistency in your weekly injection routine maximizes semaglutide's therapeutic benefits and makes tracking your progress easier. Injecting on the same day each week helps establish a habit, and many patients pair their injection day with a calendar reminder or a routine activity to ensure they never miss a dose. Rotating injection sites between your abdomen, thigh, and upper arm also reduces skin irritation and improves medication absorption.
Storage and preparation are equally important for injection success. Keep your semaglutide pen or vial in the refrigerator between 36°F and 46°F until first use, then store it at room temperature once opened for up to 30 days. Before each injection, inspect the solution for clarity—it should be colorless or slightly cloudy—and allow it to reach room temperature for five minutes to reduce injection discomfort.
How PlexusDx Personalizes Your Semaglutide Dosing Plan
PlexusDx compounded semaglutide injections start at $149 per month and remain flat across your entire treatment journey, regardless of your dose level—a commitment to transparent, predictable healthcare. Your dose may need to go up as you progress through titration, but your price won't increase, removing financial barriers to finding your optimal therapeutic level. PlexusDx serves all 50 states without requiring insurance, membership fees, or prior authorizations.
For patients seeking deeper personalization, PlexusDx offers the Precision Peptide Genetic Test, a $99 add-on after your first month of treatment that maps 14 weight-loss pathways across 49 peptides and 150+ genetic insights. This test examines variants like GLP1R rs6923761 and GIPR rs1800437 to predict how your body responds to semaglutide and whether alternative compounds like tirzepatide may offer better outcomes. HSA and FSA accounts are eligible to cover both your monthly semaglutide cost and genetic testing.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
How often do I inject semaglutide—daily, weekly, or monthly?
Semaglutide is injected once weekly, every seven days on the same day each week. This weekly cadence is fundamental to how the medication works and is not adjusted based on dose level.
What happens if I miss a weekly semaglutide injection?
If you miss your injection, take it as soon as you remember unless your next scheduled dose is fewer than two days away. If it's very close to your next dose day, skip the missed dose and resume your normal schedule. Missing a single injection will not erase your progress, though consistency yields the best results.
Does PlexusDx charge more for higher doses of semaglutide?
No. PlexusDx compounded semaglutide injections are priced at a flat $149 per month regardless of your current dose level. Your dose may increase over time during titration, but your monthly cost remains the same.
How long does the standard semaglutide titration schedule take?
Most patients complete titration in 16–20 weeks, starting at 0.25 mg and increasing by 0.25 mg increments every four weeks. PlexusDx providers can customize this timeline to match your individual tolerance and response.
Can the Precision Peptide Genetic Test help determine if weekly semaglutide injections are right for me?
Yes. The Precision Peptide Genetic Test analyzes variants in GLP1R and GIPR that influence how your body responds to once-weekly semaglutide therapy. This $99 test (available after your first treatment month) guides whether semaglutide, tirzepatide, or a dual-compound approach may work best for your genetic profile.
Related Reading
Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Does Wegovy Control Blood Sugar? Insights and Information
Tailoring Your Treatment: Can You Take 0.75 mg of Ozempic for Personalized Weight Management?